Drugs and biologicals
Ended Awarded Last action
- Contract number
- HHSN26300157
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,510
Award facts
- Contract value 50% obligated
-
- $5,509.62 Current, with exercised options
- $11,019.24 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $0 | |
| Original award | $5,510 |
About this award
This federal contract award is for DRUGS AND BIOLOGICALS, with a ceiling value of $11,019.24. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract was awarded on February 17, 2015, with a completion date of February 24, 2015. The contract is a Blanket Purchase Agreement (BPA) Call, with a Firm Fixed Price pricing type.
The funding federal agency is the Office of the Director, a civilian agency. Roche Diagnostics Corporation has multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across federal agencies, including a $37 million BPA with the Defense Health Agency for immunochemistry and clinical chemistry testing, and several VA-specific IDCs with ceiling values ranging from $208,000 to $3.1 million. Many of these contracts are established under General Services Administration (GSA) Schedule contracts, specifically the Critical Analyzers, Laboratory (FSS-66-III) and In Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedules.
Quick answers
Who was awarded contract HHSN26300157?
HHSN26300157 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on February 17, 2015.
How much is contract HHSN26300157 worth?
The government has obligated $5,510 on HHSN26300157. Its potential value, with all options, is $11,019.
Is contract HHSN26300157 an order under another contract?
Yes. HHSN26300157 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26300157 competed?
The extent of competition for HHSN26300157 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award